GIPICA

Welcome to the Brand page for “GIPICA”, which is offered here for The mark consists of the word of gipica in black and two circles connected to each other on the above the letter a, wherein the two connected circles have the designed portions in black, red and blue, and a white background color is not part of the mark.;pharmaceutical preparations for the treatment of cancer cells; cells for medical or clinical use; pharmaceutical preparations for activating cellular function; biological preparations for the treatment of immune system related disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; vaccines; pharmaceutical preparations for the treatment of cancers with t cells; pharmaceutical preparations for the treatment of cancers with car-t cells;the color(s) black, red and blue is/are claimed as a feature of the mark.;product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; dna sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics;.

Its status is currently believed to be active. Its class is unavailable. “GIPICA” is believed to be currently owned by “Eutilex Co., Ltd.”

Owner:
EUTILEX CO., LTD.
Owner Details
Description:
The mark consists of the word of GIPICA in black and two circles connected to each other on the above the letter A, wherein the two connected circles have the designed portions in black, red and blue, and a white background color is not part of the mark.;Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells;The color(s) black, red and blue is/are claimed as a feature of the mark.;Product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics;
Categories: